Several companies released diabetes study results this week, while companies like BioTime closed on their public offerings and Pixium implanted its first bionic eye. Here are 7 medtech stories we missed this week, but were still worth mentioning. 1. Insulet touts glucose control study Insulet Corp. announced the results from its first feasibility study of its Omnipod […]
FlowAid Medical Technologies
FlowAid Medical wins CE Mark for sequential contraction compression device
Blood flow and circulatory enhancement focused device developer FlowAid Medical Technologies said yesterday it won CE Mark approval in the European Union for its FA100 SCCD sequential contraction compression device. The FA100 system uses electrically stimulated controlled contractions for sequential compression, eliminating the need for external compression and pressure to the leg, according to the […]
